Health Care7 months ago
Q&A With StockPal – Neuren Pharmaceuticals (ASX:NEU)
Watch Jon Pilcher, CEO of Neuren Pharmaceuticals (ASX:NEU), speaking about Neuren’s area of drug focus and the latest updates on the Trofinetide development. 0:11 – Firstly,...
